InvestorsHub Logo
Followers 0
Posts 28
Boards Moderated 0
Alias Born 12/09/2016

Re: DollarSquad post# 1114

Wednesday, 01/18/2017 2:03:24 AM

Wednesday, January 18, 2017 2:03:24 AM

Post# of 3533
I’d take a close look at the Subsequent Events section on page F-26.

Looks to me like VSUL has really either cleaned or strengthened their balance sheet. $800k promissory notes extended, a big chunk converted?? TransTechs credit facility renewed.

Beyond that, a significant raise, in the aggregate of capital that took out the toxic instruments which was what forced the share price down so far.

What interests me most is this Pulse Bio deal, which I think is now called Biomedx. They are in a joint development and possible merger? The ceo of that company is also exec chairman of Establishment Labs. Do a little diligence on this company, it could get interesting.

I downloaded an ebook on the FAIMS technology and it looks to me like they may be complimentary--not a replacement to ChromaID. Plus VSUL seems to be a lot further down the track of commercialization.

http://www.owlstonenanotech.com/ultrafaims/imsms-news/ebook-next-5-years
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KNW News